Cardioversion

From WikiMD's WELLNESSPEDIA

Medical procedure to restore normal heart rhythm

  
Diagram of electrical cardioversion
Pronunciation
Other names
Specialty
Uses
Complications
Approach
Types
Recovery time
Other options
Frequency



Cardioversion is a medical procedure used to restore a normal heart rhythm in patients experiencing certain types of abnormal heartbeats, known as arrhythmias. The procedure can be performed using either electrical shocks or medications.

Types of Cardioversion[edit]

Electrical Cardioversion[edit]

Electrical cardioversion being performed.

Electrical cardioversion involves delivering a controlled electric shock to the heart through electrodes placed on the chest. This shock momentarily stops the heart's electrical activity, allowing the heart's natural pacemaker to restore a normal rhythm. The procedure is typically performed under sedation to ensure patient comfort.

Electrical cardioversion is often used to treat atrial fibrillation, atrial flutter, and other supraventricular tachycardias. The synchronization of the shock with the QRS complex on the electrocardiogram (ECG) is crucial to avoid inducing ventricular fibrillation.

LIFEPAK 20e Defibrillator and Monitor displaying synchronization with QRS complexes.

Pharmacological Cardioversion[edit]

Pharmacological cardioversion, also known as chemical cardioversion, involves the use of antiarrhythmic medications to restore normal heart rhythm. Commonly used drugs include amiodarone, flecainide, and propafenone. This method is often used when electrical cardioversion is not feasible or as a first-line treatment in certain cases.

Indications[edit]

Cardioversion is indicated for patients with symptomatic arrhythmias that do not resolve spontaneously and are not controlled by medications. It is particularly useful in cases of atrial fibrillation and atrial flutter, where restoring sinus rhythm can alleviate symptoms and reduce the risk of stroke.

Risks and Complications[edit]

While cardioversion is generally safe, it carries some risks, including:

  • Thromboembolism: Patients with atrial fibrillation are at risk of forming blood clots, which can dislodge during cardioversion and cause a stroke. Anticoagulation therapy is often recommended before and after the procedure.
  • Skin burns: The electrical shock can cause minor burns on the skin where the electrodes are placed.
  • Arrhythmias: In rare cases, cardioversion can induce other arrhythmias, including ventricular fibrillation.

Preparation and Procedure[edit]

Before cardioversion, patients are typically evaluated with an ECG and may undergo transesophageal echocardiography to check for blood clots in the heart. Anticoagulation therapy is often initiated to reduce the risk of stroke.

During the procedure, the patient is sedated, and electrodes are placed on the chest. The defibrillator is set to deliver a synchronized shock, and the patient's heart rhythm is monitored throughout the process.

Aftercare[edit]

Following cardioversion, patients are monitored for any complications, and their heart rhythm is assessed to ensure the procedure was successful. Long-term management may include medications to maintain sinus rhythm and prevent recurrence of arrhythmias.

Also see[edit]


Cardiovascular disease A-Z

Most common cardiac diseases

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A[edit]

B[edit]

C[edit]

D[edit]

E[edit]

H[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I[edit]

K[edit]

L[edit]

M[edit]

N[edit]

O[edit]

P[edit]

R[edit]

S[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T[edit]

V[edit]

W[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.